Essex Bio-Technology files HKEX next-day return disclosing share buyback at HKD 2.06PUBT·Sep 11 at 09:05 AM01061-0.73%
Essex Bio-Tech files HKEX next-day disclosure return on share buyback at HKD 2.07PUBT·Sep 10 at 08:43 AM01061-0.73%
The Unbundling of Hong Kong's Peripheral Market: Structural Realities in the Long TailGlobal Report·Sep 8 at 11:33 AM01613+0.57%085210.00%
The Unbundling of Legacy Nodes: A Strategic View on 10 Hong Kong EquitiesGlobal Report·Sep 8 at 10:19 AM02701-1.67%02202-0.89%
Global Capital Rotates Into Hong Kong’s Advanced Manufacturing as Legacy Sectors FractureGlobal Report·Sep 1 at 10:12 AM09630-0.58%01989-4.89%
Essex Bio-Tech files HKEX next-day disclosure after share buyback at HKD 2.17PUBT·Sep 1 at 09:10 AM01061-0.73%
Essex Bio-Tech files HKEX next-day return disclosing share repurchase at HKD 2.28-2.25PUBT·Aug 24 at 09:02 AM01061-0.73%
Essex Bio-Tech files HKEX next-day return disclosing share buyback at HKD 2.3PUBT·Aug 21 at 09:47 AM01061-0.73%
Essex Bio-Tech files HKEX next-day return on share buyback at HKD 2.3PUBT·Aug 19 at 08:48 AM01061-0.73%
Grand Pharma's FDA Nod and Sihuan's Aesthetics Pivot Highlight HK Market ShiftsGlobal Report·Aug 11 at 10:13 AM02695-0.87%03288+0.07%
Essex Bio-Tech files HKEX next-day return disclosing share repurchase at HKD 2.37PUBT·Aug 7 at 08:52 AM01061-0.73%
Essex Bio-Technology Reports Profit Decline but Strong Balance Sheet in First-Half 2026Tip Ranks·Aug 5 at 11:39 AM01061-0.73%
Essex Bio-Technology Declares Interim Dividend for First Half of 2026Tip Ranks·Aug 5 at 11:39 AM01061-0.73%
Essex Bio-Technology FY26 H1 profit drops 32.2% to HK$ 110.72 million; revenue falls 10.5% to HK$ 784.69 millionPUBT·Aug 5 at 11:24 AM01061-0.73%
Essex Bio-Tech schedules board meeting to review interim results, consider dividendPUBT·Jul 24 at 09:00 AM01061-0.73%
